Dova Pharmaceuticals

[anonymous]

Soon because they want to avoid paying the LTI $ and we heard from high level source that no one is going to the national meeting who won't be retained for the long term in Hem division.

Is there a time frame? We keep being told that hematology is a growth driver

 

[anonymous]

Soon because they want to avoid paying the LTI $ and we heard from high level source that no one is going to the national meeting who won't be retained for the long term in Hem division.

Any chance you can share the high level source? Only thing we hear is that hematology is the growth franchise

 

[anonymous]

Any chance you can share the high level source? Only thing we hear is that hematology is the growth franchise

Hematology is a growth franchise and pac will continue to grow, but the number of reps in this franchise is about 25% more than what is needed. Senior leadership had this explained to them from the CTI folks, but decided they knew better.

 

[anonymous]

Hematology is a growth franchise and pac will continue to grow, but the number of reps in this franchise is about 25% more than what is needed. Senior leadership had this explained to them from the CTI folks, but decided they knew better.

BS! Neither drug has a future. The MF combos launch next year, all include rux and pac will become an after thought, think fedratinib. Huge layoff if they keep the hem group at all.

 

[anonymous]

BS! Neither drug has a future. The MF combos launch next year, all include rux and pac will become an after thought, think fedratinib. Huge layoff if they keep the hem group at all.

This is correct. Pac has been old news since Mom launched last year. The same fools who paid a fortune for an insolvent company just to get Pac failed to plan for the obvious GSK launch and failed to get Pac included in the combo trials. No future here for Hem since Sobi has no R+D and the Board will never approve another purchase after this disaster.